Stay updated on Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page adds an explicit NIH grant/contract note for 2019 and updates the page revision tag to v3.6.6 (replacing v3.6.5).SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website revision identifier was updated from v3.6.4 to v3.6.5, indicating a new build of the ClinicalTrials.gov interface. This represents an internal release update and does not alter the displayed study details or user-facing content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating an update to the page template or rendering system. This change is an internal version bump and does not alter the study content or data displayed.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating a site/template update. This change updates the page's version label and does not modify any study data or user-visible content.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page revision has been updated to v3.6.2, replacing the previous v3.6.0. This indicates a content update to the ClinicalTrials.gov entry without changing core study details.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page now indicates recruitment has ended. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention header was updated from 'Intervention / Treatment' to 'Intervention/Treatment', along with a Revision: v3.6.0 note.SummaryDifference0.3%

Stay in the know with updates to Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.